Replay available

PROCEPT BioRobotics Corporation (PRCT) Q4 2025 Earnings Call

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Q4 2025 earnings conference call, held 2026-02-25. Replay captured from the company's public earnings webcast.

Wed, February 25, 2026 at 4:30 PMendedReplay
PROCEPT BioRobotics Corporation (PRCT) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Matt Basko

Vice President, Investor Relations

Larry Wood

Chief Executive Officer

Kevin Waters

Chief Financial Officer

Matthew O'Brien

Analyst, Piper Sandler

Chris Pasquale

Analyst, Nephron Research

Josh Jennings

Analyst, TD Cowen

Richard Newwitter

Analyst, Truist Securities

Brandon Vasquez

Analyst, William Blair

Suraj Kalia

Analyst, Oppenheimer & Co.

Michael Sarcone

Analyst, Jefferies

Stephanie Piazzolla

Analyst, Bank of America

Daniela and Taffy

Analysts, UBS

Mike Kratke

Analyst, LearLink Partners

Nathan Trebek

Analyst, Wells Fargo

Replay transcript excerpt

Good afternoon and welcome to the Procept by Robotics fourth quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. We will be facilitating a question and answer session toward the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the conference over to Matt Basko, Vice President, Investor Relations, for a few introductory comments. Please go ahead. Good afternoon, and thank you for joining Procept Biorobotics' fourth quarter 2025 earnings conference call. Presenting on today's call are Larry Wood, Chief Executive Officer, and Kevin Waters, Chief Financial Officer. Before we begin, I'd like to remind listeners that statements made on this conference call that relate to future plans, events, or performance are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. While these four looking statements are based on management's current expectations and beliefs, these statements are subject to several risks, uncertainties, assumptions, and other factors that could cause results to differ materially from the expectations expressed on this conference call. These risks and uncertainties are disclosed in more detail in Procept Biorobotics filings with the Securities Exchange Commission, all of which are available online at www.sec.gov. Listeners are cautioned not to place under reliance on these forward-looking statements, which speak only as of today's date, February 24th, 2026. Except as required by law, Procept Biorobotics undertakes no obligation to update or revise any forward-looking statements to reflect new information, circumstances, or unanticipated events that may arise. During the call, we will also reference certain fina...

More from Procept Biorobotics Corporation